MX164971B - Procedimiento para la preparacion de conjugados de medicamentos citoxicos - Google Patents
Procedimiento para la preparacion de conjugados de medicamentos citoxicosInfo
- Publication number
- MX164971B MX164971B MX17079A MX1707989A MX164971B MX 164971 B MX164971 B MX 164971B MX 17079 A MX17079 A MX 17079A MX 1707989 A MX1707989 A MX 1707989A MX 164971 B MX164971 B MX 164971B
- Authority
- MX
- Mexico
- Prior art keywords
- cytoxic
- conjugates
- medicines
- procedure
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/230,084 US5006652A (en) | 1988-08-08 | 1988-08-08 | Intermediates for antibody-vinca drug conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX164971B true MX164971B (es) | 1992-10-09 |
Family
ID=22863896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX17079A MX164971B (es) | 1988-08-08 | 1989-08-04 | Procedimiento para la preparacion de conjugados de medicamentos citoxicos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5006652A (es) |
| EP (1) | EP0354728A3 (es) |
| JP (1) | JPH02131499A (es) |
| KR (1) | KR900002804A (es) |
| CN (1) | CN1040205A (es) |
| AR (1) | AR245368A1 (es) |
| AU (1) | AU619329B2 (es) |
| DK (1) | DK382989A (es) |
| HU (1) | HU206377B (es) |
| IL (1) | IL91182A0 (es) |
| MX (1) | MX164971B (es) |
| NZ (1) | NZ230200A (es) |
| PH (1) | PH27351A (es) |
| PT (1) | PT91372A (es) |
| ZA (1) | ZA895908B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776093A (en) | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
| AU633867B2 (en) * | 1989-02-02 | 1993-02-11 | Eli Lilly And Company | Delivery of cytotoxic agents |
| US5272253A (en) * | 1991-07-01 | 1993-12-21 | Eli Lilly And Company | Cluster conjugates of drugs with antibodies |
| GR1001459B (el) * | 1992-10-08 | 1993-12-30 | Lilly Co Eli | Σύμπλεγμα συζυγών φαρμάκων με αντισώματα. |
| ES2049656B1 (es) * | 1992-10-08 | 1994-11-16 | Lilly Co Eli | Grupos de conjugados de farmacos con anticuerpos. |
| US5773001A (en) * | 1994-06-03 | 1998-06-30 | American Cyanamid Company | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| US20030119724A1 (en) * | 1995-11-22 | 2003-06-26 | Ts`O Paul O.P. | Ligands to enhance cellular uptake of biomolecules |
| EP1355672A2 (en) | 2000-12-01 | 2003-10-29 | Cell Works Inc. | Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
| DE60231868D1 (de) * | 2001-04-24 | 2009-05-20 | Purdue Research Foundation | Folat-mimetika und deren folatrezeptorbindende konjugate |
| DE60326833D1 (de) * | 2002-05-15 | 2009-05-07 | Endocyte Inc | Vitamin-mitomycin-konjugate |
| EP2529758A3 (en) | 2003-01-27 | 2013-01-02 | Endocyte, Inc. | Vitamin receptor binding drug delivery conjugates |
| US8288557B2 (en) | 2004-07-23 | 2012-10-16 | Endocyte, Inc. | Bivalent linkers and conjugates thereof |
| US8044200B2 (en) * | 2005-03-16 | 2011-10-25 | Endocyte, Inc. | Synthesis and purification of pteroic acid and conjugates thereof |
| KR101364912B1 (ko) * | 2005-08-19 | 2014-02-21 | 엔도사이트, 인코포레이티드 | 복수-약제 리간드 공액체 |
| WO2007022493A2 (en) * | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Ligand conjugates of vinca alkaloids, analogs, and derivatives |
| US20100104626A1 (en) * | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| NZ580132A (en) * | 2007-03-14 | 2012-11-30 | Endocyte Inc | Binding ligand linked drug delivery conjugates of tubulysins to vitamins |
| US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| AU2008268432B2 (en) * | 2007-06-25 | 2015-01-15 | Endocyte, Inc. | Conjugates containing hydrophilic spacer linkers |
| EP2209374B1 (en) * | 2007-10-25 | 2014-12-03 | Endocyte, Inc. | Tubulysins and processes for preparing |
| WO2013126797A1 (en) | 2012-02-24 | 2013-08-29 | Purdue Research Foundation | Cholecystokinin b receptor targeting for imaging and therapy |
| US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
| CA2887727A1 (en) | 2012-10-16 | 2014-04-24 | Endocyte, Inc. | Drug delivery conjugates containing unnatural amino acids and methods for using |
| JP6431038B2 (ja) | 2013-03-15 | 2018-11-28 | ザイムワークス インコーポレイティド | 細胞毒性及び抗有糸分裂性化合物とその使用方法 |
| KR102384740B1 (ko) | 2013-12-27 | 2022-04-07 | 자임워크스 인코포레이티드 | 약물 접합체를 위한 설폰아마이드-함유 연결 시스템 |
| HUE057768T2 (hu) | 2014-09-17 | 2022-06-28 | Zymeworks Inc | Citotoxikus és antimitotikus vegyületek és azok alkalmazásának módszerei |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4203898A (en) * | 1977-08-29 | 1980-05-20 | Eli Lilly And Company | Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids |
| FI820020L (fi) * | 1981-01-12 | 1982-07-13 | Lilly Industries Ltd | Immunoglobulinkonjugater |
| US4631190A (en) * | 1981-06-26 | 1986-12-23 | Shen Wei C | Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers |
| CA1203164A (en) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Antibody conjugates |
| US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| DK167884A (da) * | 1983-03-30 | 1984-10-01 | Lilly Industries Ltd | Immunoglobulinkonjugater |
| EP0124502B1 (fr) * | 1983-04-29 | 1991-06-12 | OMNICHEM Société anonyme | Nouveaux conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques contenant ces conjugués |
| LU86157A1 (fr) * | 1985-11-12 | 1987-06-26 | Omnichem Sa | Nouveau procede de fabrication de conjugues de la vinblastine et de ses derives |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| EP0232693A3 (fr) * | 1985-12-16 | 1988-04-06 | La Region Wallonne | Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| GB8610551D0 (en) * | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
| ZA873600B (en) * | 1986-05-27 | 1988-12-28 | Lilly Co Eli | Immunoglobulin conjugates |
| US4997913A (en) * | 1986-06-30 | 1991-03-05 | Oncogen | pH-sensitive immunoconjugates and methods for their use in tumor therapy |
| FR2610198B1 (fr) * | 1987-02-03 | 1990-06-15 | Ire Celltarg Sa | Conjugues d'hydrazide d'alcaloide de vinca lie a une immunoglobuline, procede de preparation et compositions pharmaceutiques en comprenant |
| IL89043A0 (en) * | 1988-01-27 | 1989-08-15 | Lilly Co Eli | Antibody conjugates |
-
1988
- 1988-08-08 US US07/230,084 patent/US5006652A/en not_active Expired - Fee Related
-
1989
- 1989-08-02 IL IL91182A patent/IL91182A0/xx unknown
- 1989-08-02 ZA ZA895908A patent/ZA895908B/xx unknown
- 1989-08-03 NZ NZ230200A patent/NZ230200A/xx unknown
- 1989-08-03 EP EP19890307915 patent/EP0354728A3/en not_active Ceased
- 1989-08-03 PT PT91372A patent/PT91372A/pt unknown
- 1989-08-04 PH PH39050A patent/PH27351A/en unknown
- 1989-08-04 AU AU39339/89A patent/AU619329B2/en not_active Ceased
- 1989-08-04 MX MX17079A patent/MX164971B/es unknown
- 1989-08-04 DK DK382989A patent/DK382989A/da not_active Application Discontinuation
- 1989-08-04 AR AR89314592A patent/AR245368A1/es active
- 1989-08-07 CN CN89105544A patent/CN1040205A/zh active Pending
- 1989-08-07 HU HU893992A patent/HU206377B/hu not_active IP Right Cessation
- 1989-08-07 KR KR1019890011217A patent/KR900002804A/ko not_active Application Discontinuation
- 1989-08-07 JP JP1205545A patent/JPH02131499A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PH27351A (en) | 1993-06-21 |
| NZ230200A (en) | 1991-11-26 |
| KR900002804A (ko) | 1990-03-23 |
| IL91182A0 (en) | 1990-03-19 |
| JPH02131499A (ja) | 1990-05-21 |
| HUT50488A (en) | 1990-02-28 |
| EP0354728A3 (en) | 1991-04-10 |
| HU206377B (en) | 1992-10-28 |
| DK382989A (da) | 1990-02-09 |
| ZA895908B (en) | 1991-04-24 |
| AU619329B2 (en) | 1992-01-23 |
| PT91372A (pt) | 1990-03-08 |
| AR245368A1 (es) | 1994-01-31 |
| EP0354728A2 (en) | 1990-02-14 |
| DK382989D0 (da) | 1989-08-04 |
| CN1040205A (zh) | 1990-03-07 |
| US5006652A (en) | 1991-04-09 |
| AU3933989A (en) | 1990-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX165003B (es) | Procedimiento para la preparacion de conjugados de medicamentos citotoxicos | |
| MX164971B (es) | Procedimiento para la preparacion de conjugados de medicamentos citoxicos | |
| DK481989A (da) | Farmaceutiske formuleringer | |
| DK89090D0 (da) | Farmaceutisk praeparat | |
| DK229489D0 (da) | Laegemiddeladsorbater | |
| DK489189D0 (da) | Farmaceutisk praeparat | |
| BR8901027A (pt) | Inalador pediatrico para medicacao | |
| BG91785A (bg) | Лекарствена форма | |
| DK705488D0 (da) | Farmaceutisk praeparat | |
| PT92213A (pt) | Processo para a preparacao de conjugados de anticorpo-droga | |
| MX14533A (es) | Procedimiento para la preparacion de compuestos farmaceuticos | |
| DK603988D0 (da) | Farmaceutisk praeparat | |
| DK496889A (da) | Peptidholdigt farmaceutisk praeparat | |
| DK336489A (da) | Farmaceutisk praeparat | |
| ES2013216A4 (es) | Proceso para la preparacion de n - fosfonometilglicina | |
| MX17041A (es) | Procedimiento para la preparacion de benzopirano pirazoles. | |
| DK139388A (da) | Farmaceutisk praeparat | |
| MX15050A (es) | Procedimiento para la preparacion de derivados de 1-arilsulfinil-2-pirrolidinona. | |
| DK276288A (da) | Farmaceutisk praeparat | |
| NO891574D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
| IT1227462B (it) | Procedimento di preparazione di 6-ossopenicillanati | |
| DK37589A (da) | Farmaceutisk praeparat for 4-aroylimidazol-2-oner | |
| ATA321188A (de) | Pharmazeutische zubereitung | |
| DE3824370A1 (de) | Dermatologisches praeparat | |
| MX18036A (es) | Procedimiento para la preparacion de penems |